Literature DB >> 15234304

Successful treatment of subfoveal choroidal neovascularization associated with combined hamartoma of the retina and retinal pigment epithelium.

Makoto Inoue1, Koushuke Noda, Susumu Ishida, Takefumi Yamaguchi, Norihiro Nagai, Kei Shinoda, Hajime Shinoda, Yoshihisa Oguchi.   

Abstract

PURPOSE: To describe a patient with subfoveal choroidal neovascularization (CNV) associated with combined hamartoma of the retina and retinal pigment epithelium (CHRRPE), treated successfully by submacular surgery.
DESIGN: Interventional case report.
METHODS: A 12-year-old girl was referred to our clinic for evaluation. Visual acuity was 20/30 in the affected left eye. Ophthalmoscopy disclosed juxtapapillary CHRRPE and subfoveal pigmented CNV. Vitreous surgery was carried out because of visual deterioration to 20/60.
RESULTS: The posterior vitreous was strongly attached to glial tissue at the superior margin of the optic disk in the CHRRPE region. The CNV, which was not connected with the CHRRPE, was carefully removed, resulting in visual improvement to 20/20 5 months after surgery. Histologically, the excised membrane showed fibroblast-rich cellular component and a type 2 configuration.
CONCLUSION: Submacular surgery can be effective for the treatment of secondary CNV associated with CHRRPE.

Entities:  

Mesh:

Year:  2004        PMID: 15234304     DOI: 10.1016/j.ajo.2004.02.020

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  2 in total

1.  Peripheral combined hamartoma of the retina and retinal pigment epithelium with remote peripapillary choroidal neovascular membrane.

Authors:  Thomas A Lazzarini; Hasenin Al-Khersan; Nimesh A Patel; Jonathan F Russell; Kenneth C Fan; Giselle De Oliveira; Catherin I Negron; Elias Mavrofrides; Audina M Berrocal
Journal:  Am J Ophthalmol Case Rep       Date:  2020-10-01

2.  Choroidal neovascularization associated with combined hamartoma of retina and retinal pigment epithelium: Multimodal imaging.

Authors:  Rajan Gupta; Rajeev R Pappuru; Vivek P Dave; Jay Chhablani
Journal:  Indian J Ophthalmol       Date:  2018-12       Impact factor: 1.848

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.